Medical News

RSS

Metabolic syndrome components may influence LUTS/BPH

Abdominal aortic calcification and visceral fat obesity each seem to influence lower urinary tract symptoms in men with benign prostatic hyperplasia, study findings suggest.

30 Jun 2014

Pre-op assessment could improve post-op pain after arthroplasty

Spanish researchers have developed recommendations on how to assess and manage preoperative pain in patients undergoing total knee or total hip replacement.

30 Jun 2014

Tonsillectomy in adults improves quality of life

Tonsillectomy for recurrent pharyngitis in adults improves quality of life for the overwhelming majority of patients, report researchers.

30 Jun 2014

Genetic variants alter chance of sunitinib dose reduction

Scientists have identified genetic variants that reduce the likelihood of sunitinib dose reduction in patients with metastatic renal cell carcinoma.

30 Jun 2014

Causal role proposed for vitamin D in blood pressure

The results of a mendelian randomisation analysis suggest a causal link between low levels of vitamin D and increased blood pressure.

30 Jun 2014

18F-FGD-PET measures predict mRCC TKI response

Positron emission tomography could be used to predict the response of metastatic renal cell carcinoma to tyrosine kinase inhibitor therapy within a couple of weeks of a patient beginning treatment, research suggests.

30 Jun 2014

Vitamin D may not ward off Type 2 diabetes

Vitamin D supplementation is unlikely to improve glycaemic measures in people with prediabetes, show the findings of a randomised trial.

30 Jun 2014

WHO recommends women's groups to improve maternal and newborn health

The World Health Organisation has recommended an intervention developed and tested by partners in four countries and UCL researchers to improve maternal and newborn health.

30 Jun 2014

Abortion issue drives campaigns

Senate Minority Leader Mitch McConnell (R-Ky.) promises to do more to limit abortions if Republicans take control of the U.S. Senate, while Wendy Davis, the Democratic nominee for Texas governor, tried to galvanize support a year after her marathon filibuster in the state legislature against abortion restrictions.

30 Jun 2014

Covenant and Sartori medical centers deploy TRU-D SmartUVC superbug-slaying robot

Wheaton Franciscan Healthcare-Iowa is the latest to deploy TRU-D SmartUVC, a 5-foot-5 germ-killing ultraviolet robot equipped with the only infection prevention data collection and reporting software on the market. TRU-D is now in use at Covenant Medical Center in Waterloo and Sartori Medical Center in Cedar Falls, Iowa.

30 Jun 2014

Advocates and critics brace for High Court decision on contraceptive mandate

The Supreme Court is expected to release its ruling today on a case brought by the owners of Hobby Lobby craft store and Conestoga Wood Specialties Corp., who object to being forced to offer some types of birth control.

30 Jun 2014

Children's of Alabama extends its commitment to Allscripts Sunrise EHR solutions

Allscripts has announced that Birmingham-based Children's of Alabama has extended its commitment to Allscripts Sunrise™ electronic health record (EHR) through 2023 and will leverage a suite of Allscripts open platform solutions to support its efforts to meet regulatory requirements, manage population health and improve patient outcomes.

30 Jun 2014

FSC Laboratories acquires exclusive marketing rights for Aciphex Sprinkle in the U.S.

FSC Therapeutics, LLC, today announced that the Company has entered into a transaction with Eisai Inc. to acquire exclusive U.S. marketing rights for AcipHex® Sprinkle™ (rabeprazole sodium), Delayed-Release Capsules, 5 mg and 10 mg, for the treatment of Gastroesophageal Reflux Disease (GERD) in children 1 to 11 years of age for up to 12 weeks.

30 Jun 2014

Merck reports results from global EMEND Phase 3 study for CINV prevention in pediatric cancer patients

Merck, known as MSD outside the United States and Canada, today announced results from a global, investigational Phase 3 study to evaluate the safety and efficacy of EMEND (aprepitant) in the prevention of chemotherapy-induced nausea and vomiting (CINV) in pediatric cancer patients, aged 6 months to 17 years.

30 Jun 2014

ANMAT approves Genzyme’s Lemtrada for treatment of relapsing remitting multiple sclerosis

Genzyme, a Sanofi company (EURONEXT:SAN and NYSE:SNY), announced today that Argentina's National Administration of Drugs, Food and Medical Technology (ANMAT) has approved LemtradaTM (alemtuzumab) for adult patients with relapsing remitting multiple sclerosis (RRMS) with active disease defined by clinical or imaging features.

30 Jun 2014

Omega-3 PUFAs offer an affordable way to reduce effects of traumatic brain, spinal cord injuries

The omega-3 polyunsaturated fatty acids (PUFAs) found in seafood and marine oils called EPA and DHA may offer a simple, affordable way to reduce the effects of traumatic brain and spinal cord injuries by decreasing inflammation and nerve cell damage.

30 Jun 2014

Medican Enterprises is in negotiations to purchase 51% of International Herbs Medical Marijuana

Medican Enterprises, Inc. a bio-pharmaceutical company in the emerging global medical marijuana industry is pleased to announce it is currently negotiating the purchase of 51% of International Herbs Medical Marijuana Ltd ("IHMML").

30 Jun 2014

Stryker Corporation to acquire all assets of Small Bone Innovations for $375M

Small Bone Innovations, Inc. (SBi) today announced that Stryker Corporation will acquire substantially all the assets of SBi in an all cash transaction for up to $375 million.

From Stryker 30 Jun 2014

Actavis seeks FDA ANDA approval for generic Zubsolv, confirms patent challenge

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate Sublingual Tablets, Eq, 1.4 mg/0.36 mg and 5.7 mg/1.4 mg Base. Actavis' ANDA product is a generic version of Orexo's Zubsolv, which is a partial opioid agonist indicated for the maintenance treatment of opioid dependence.

30 Jun 2014

Cidara Therapeutics closes $32M Series A financing to advance novel echinocandin antifungal drug

Cidara Therapeutics, Inc., a privately held biopharmaceutical company, announced today that it has completed a $32 million Series A financing that will enable it to advance candidates from the company's Cloudbreak™ targeted immunotherapy platform and biafungin™, a novel long acting echinocandin antifungal drug, into human clinical studies.

30 Jun 2014

Medical News

Metabolic syndrome components may influence LUTS/BPH

Pre-op assessment could improve post-op pain after arthroplasty

Tonsillectomy in adults improves quality of life

Genetic variants alter chance of sunitinib dose reduction

Causal role proposed for vitamin D in blood pressure

18F-FGD-PET measures predict mRCC TKI response

Vitamin D may not ward off Type 2 diabetes

WHO recommends women's groups to improve maternal and newborn health

Abortion issue drives campaigns

Covenant and Sartori medical centers deploy TRU-D SmartUVC superbug-slaying robot

Advocates and critics brace for High Court decision on contraceptive mandate

Children's of Alabama extends its commitment to Allscripts Sunrise EHR solutions

FSC Laboratories acquires exclusive marketing rights for Aciphex Sprinkle in the U.S.

Merck reports results from global EMEND Phase 3 study for CINV prevention in pediatric cancer patients

ANMAT approves Genzyme’s Lemtrada for treatment of relapsing remitting multiple sclerosis

Omega-3 PUFAs offer an affordable way to reduce effects of traumatic brain, spinal cord injuries

Medican Enterprises is in negotiations to purchase 51% of International Herbs Medical Marijuana

Stryker Corporation to acquire all assets of Small Bone Innovations for $375M

Actavis seeks FDA ANDA approval for generic Zubsolv, confirms patent challenge

Cidara Therapeutics closes $32M Series A financing to advance novel echinocandin antifungal drug

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News